Wipfli Financial Advisors’s Maravai LifeSciences MRVI Stock Holding History

Wipfli Financial Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5K	Buy	+180	New	+$4.52K	﹤0.01%	2081

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Wipfli Financial Advisors's MRVI Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Maravai LifeSciences (MRVI) in Q3 2022: 180 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #2081 among its holdings.

202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

Wipfli Financial Advisors held 180 shares of Maravai LifeSciences worth $5K as of Q3 2022.
Maravai LifeSciences was a new Wipfli Financial Advisors position in Q3 2022.
Maravai LifeSciences made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2081 holding.
202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.